menu
0
search
search
    close

    Savoy Pharmaceuticals

    Developer of products to treat cancer and terminal viral diseases

      Description

      Developer of products to treat cancer and terminal viral diseases. Thehcompany develops products to treat cancer and terminal viral diseases including liver cancer, pancreatic cancer, breast cancer, colon cancer, Hepatitis C, HIV and Herpes.

      Company Status

      The company raised $2.5 million of angel funding from undisclosed investors on January 28, 2014.

      Primary Industry Sector / Group / Code
      Verticals
      Service Providers
      Keywords
      cancer treatment therapy, oncology and virology, therapeutic company, therapy
      General Information
      • All Industries
        Other Pharmaceuticals and Biotechnology*
      • Company Financing Status
        Angel-Backed
      • Total Raised
        $2.50M
      • Business Status
        Startup
      • Ownership Status
        Privately Held (backing)
      • Universe
        Pre-venture
      • Website
        http://www.savoypharmaceuticals.com
      • Year Founded
        2004
      Employees
      • Employees
        4
      • Employee History
      Investors
      Acquirers
      Signals Summary – Growth rates
      • Growth Rate Percentile
        34
      • Web Growth Rate Percentile
        28
      • Majestic Growth Rate Percentile
        30
      Web signals
      • Majestic Referring Domains
        3
      Signals Summary – Size multiple
      • Size Multiple
        0.07x
      • Size Multiple Percentile
        6
      • Size Multiple % Change
        2.17%
      • Web Size Multiple
        0.07x
      • Web Size Multiple Percentile
        6
      • Majestic Size Multiple
        0.07x
      • Majestic Size Multiple Percentile
        6
      First Financing
      • First Financing Date
        January 28, 2014
      • First Financing Size
        $2.50M
      • First Financing Size Status
        Actual
      • First Financing Valuation
        $102.50M
      • First Financing Valuation Status
        Actual
      • First Financing Deal Type
        Angel (individual)
      • First Financing Deal Type 2
        Angel (individual)
      • First Financing Deal Class
        Individual
      • First Financing Status
        Completed
      Last Financing
      • Last Financing Date
        January 28, 2014
      • Last Financing Size
        $2.50M
      • Last Financing Size Status
        Actual
      • Last Financing Valuation
        $102.50M
      • Last Financing Valuation Status
        Actual
      • Last Financing Deal Type
        Angel (individual)
      • Last Financing Deal Type 2
        Angel (individual)
      • Last Financing Deal Class
        Individual
      • Last Financing Status
        Completed
      Location
      Get Directions
      Primary Contact
      • Primary Contact
        Nathaniel Lallatin
      • Primary Contact Title
        Founder & Board Member
      Headquarters
      • HQ Location
        2825 E Cottonwood Pkwy, Cottonwood Heights, UT 84121, USA
      • HQ Address Line 1
        2825 East Cottonwood Parkway
      • HQ City
        Salt Lake City
      • HQ State/Province
        Utah
      • HQ Post Code
        84121
      • HQ Country
        United States
      • HQ Email
        customerservice@savoypharmaceuticals.com
      • HQ Global Region
        Americas
      • HQ Global Sub Region
        North America
      mood_bad
    • No comments yet.
      • chat
      Add a review

      Leave a Reply ·

      keyboard_arrow_up